By Satyam Kumar
As India heads into election season, markets have been seeing a lot of volatility. While the Nifty 50 saw gains early in the year, March saw the index closing lower amid worries about stock market valuations, global geopolitical tensions and rising oil prices.
While banking and finance stocks were leading the rally over the past year, the last few months have seen real estate and general industrials gain traction. A pick-up in exports in FY25 is expected to boost manufacturing, metals and industrials in the coming quarters.
Indian equity mutual funds saw a net inflow of Rs 22,633 crore in March. All categories, except for small cap funds saw net inflows as investors pulled out money from smallcaps for the first time in the last two and half years. For the equity category, the total inflows in FY24 stood at Rs 1.8 lakh crore, up 25% YoY.

Stocks with increasing MF holding - SAIL, Crompton Greaves, Max Health, Aster DM, Prestige
SAIL eyes growth with capacity expansion
Steel Authority of India (SAIL) is in the business of making steel and is one of the Maharatnas among India’s Central Public Sector Enterprises. The company owns five steel plants at Bhilai, Rourkela, Durgapur, Bokaro and Burnpur (Asansol) and three special steel plants at Salem, Durgapur and Bhadravathi. It also owns a Ferro Alloy plant at Chandrapur.
The firm posted volume growth of 9% YoY in 9MFY24 to 12.5 million tonnes (MT). The company plans to maximize volume further to counter falling prices. It is also planning additional capex in phases, starting with an expansion of 4.5 MT in its IISCO plant, and by 3 MT at Bokaro. With a current steel capacity of 20.6 MT, SAIL is aiming to reach 35 MT steel capacity by FY32.
Fund managers who bought shares of SAIL
Fund managers who added shares of Steel Authority of India to their portfolios include Alok Singh for Bank of India ELSS Tax Saver Fund, Sanjeev Sharma and Vasav Sahgal for Quant Mid Cap Fund, and Abhishek Bisen and Hiten Shah for Kotak Equity Savings Fund. Fresh buys were done by Manish Lodha and Abhinav Khandelwal for Mahindra Manulife Small Cap Fund, and Dhimant Shah and Rohan Korde for ITI Focused Equity Fund.
Crompton Greaves stands to gain from the hot summer
Crompton Greaves Consumer Electricals (CROMPTON) is a home appliances manufacturer with a focus on the fans business, which generates around 45% of its revenue. The pump business contributes 22%, while Crompton’s appliance and lighting business constitutes around 16% each. Its Butterfly Gandhimathi acquisition and other new products add 13% and 15% respectively to the total sales.
As the summer season approaches its peak, the company stands to gain with its strong presence in the mass category, with fans priced below Rs 2,000. With its current market share at 27-28%, the company hopes to gain additional share by focusing on its premium & super premium fans, and better channel mix. However, product diversification is very crucial for the overall growth of the company.
Fund managers who bought shares of Crompton Greaves
Fund managers who added shares of Crompton Greaves Consumer Electricals to their portfolios include Neelesh Surana for Mirae Asset ELSS Tax Saver Fund, Roshi Jain and Dhruv Muchhal for HDFC Flexi Cap Fund, Kiran Sebastian and R. Janakiraman for Franklin India Opportunities Fund. Fresh buys were done by Manish Gunwani and Viraj Kulkarni for Bandhan Flexi Cap Fund and Anand Sharma and Sharmila D’mello for ICICI Prudential Housing Opportunities Fund.
Max Healthcare has the highest ARPOB among its peers
Max Healthcare Institute (MAXHEALTH) is primarily engaged in the business of healthcare services through its clinics, multi-specialty and super-specialty hospitals. Operating mainly in metro/tier-1 cities, they have 17 healthcare facilities with over 3,500 beds in NCR Delhi, Haryana, Punjab, Uttarakhand and Maharashtra. Apart from hospitals, they also have a home care and pathology business under the name Max@Home and Max Labs respectively.
With occupancy level at or above 75% for the past 3 years and consistent growth in ARPOB (average revenue per occupied bed), Max Healthcare boasts the highest operating EBITDA margins among its peers at 28%. The company plans to add six new facilities to its existing network. At the same time, the company is also exploring inorganic opportunities to expand.
Fund managers who bought shares of Max Healthcare
Fund managers who added shares of Max Healthcare Institute to their portfolios include Bhavin Vithlani and Pradeep Kesavan for SBI Magnum Midcap Fund, Venkatesh Sanjeevi and R. Janakiraman for Franklin India Equity Advantage Fund, and Aditya Khemani and Amit Ganatra for Invesco India Large&MidCap Fund. Fresh buys were done by Niket Shah and Ankush Sood for Motilal Oswal Midcap Fund, and Shreyash Devalkar and Ashish Naik for Axis ELSS Tax Saver Fund.
Aster DM Healthcare trades at cheap valuations post GCC divestment
Aster DM Healthcare (ASTERDM) has a chain of hospitals in India and the Gulf Cooperation Council (GCC). However, on December 1, 2023, the company announced its plan to sell its GCC business for over a billion dollars. After the sale of its GCC business for $1.3 billion (approx Rs 10,846.3 crore), the company announced a dividend of Rs 118 per share with April 23 set as the record date for the payout.
With an operating profit margin of 20%, the company has guided for margin improvement of 300-400 bps over the next three years. Key drivers for growth will be the faster ramp up of its new Whitefeild unit and occupancy scale-up at its existing hospitals. Given the growth profile, the hospital chain has been trading at cheap valuations compared to its peers. With investors looking for cheaper stocks in an expensive market, the company has rallied 20.5% in the past month.
Fund managers who bought shares of Aster DM Healthcare
Fund managers who added shares of Aster DM Healthcare to their portfolios include Chirag Setalvad and Dhruv Muchhal for HDFC Small Cap Fund, R. Janakiraman and Sandeep Manam for Franklin India Smaller Companies Fund, and Bhavesh Jain for Edelweiss Nifty Smallcap 250 Index Fund. Fresh buys were done by Samir Rachh and Kinjal Desai for Nippon India Small Cap Fund, and Sankaran Naren and Dharmesh Kakkad for ICICI Prudential Value Discovery Fund.
Prestige Estates rise on the back strong demand for residentials
Prestige Estates Projects (PRESTIGE) is a realty company based out of Bangalore, India. This real estate development business operates in the residential, office, retail and hospitality segments. Prestige has completed over 300 projects and delivered over 180 million square Feet, and has another 170 million square feet under development.
In FY24, the company has posted sales bookings at Rs 21,040 crore, which is up 63% YoY. Over the same time, the company has seen annual collections of Rs 11,954 crore, up 22% YoY. This was on the back of strong demand for its residential properties and higher average per square feet realisation. Future growth prospects look intact, given the increasing demand for residential properties and its launch pipeline.
Fund managers who bought shares of Prestige Estates
Fund managers who added shares of Prestige Estates Projects to their portfolios include Neelesh Surana and Ankit Jain for Mirae Asset Large & Midcap Fund, Niket Shah and Ankush Sood for Motilal Oswal Flexicap Fund, and Gopal Agrawal and Dhruv Muchhal for HDFC Multi Cap Fund. Fresh buys were done by Amit Ganatra and Taher Badshah for Invesco India Contra Fund, and Venugopal Manghat and Cheenu Gupta for HSBC Midcap Fund.

Stocks with increasing MF holding - Star Health, Suven, Aavas Fin, Quess Corp, MGL
Star Health hopes to drive market share growth with PhonePe partnership
Star Health and Allied Insurance (STARHEALTH), a banking and finance firm headquartered in Chennai, is India's first Standalone Health Insurance provider. It provides coverage ranging from health, personal accident and overseas travel insurance. The company has a market share of 33% in the retail health segment. It has one of the largest health insurance hospital networks in India, with more than 12,820 hospitals as of 31 March, 2022.
Star Health’s revenue growth moderated to 16.4% YoY in Q3FY24 due to its retail and corporate health insurance segments. Star Health & Allied Insurance also entered a strategic partnership with PhonePe to offer insurance policies. With this partnership, Star Health’s health insurance policies will be available, with monthly and annual payment options, on the PhonePe app.
Fund managers who bought shares of Star Health
Fund managers who added shares of Star Health and Allied Insurance to their portfolios include Shobhit Mehrotra and Srinivasan Ramamurthy for HDFC Retirement Savings Fund, V Srivatsa and Sunil Patil for UTI Aggressive Hybrid Fund, Ankush Sood and Rakesh Shetty for Motilal Oswal Focused Regular Growth Fund,and Atul Penkar and Dhaval Joshi for Aditya Birla Sun Life ELSS Fund. Fresh buys were done by Mittul Kalawadia and Sharmila D’mello for ICICI Prudential ELSS Tax Saver Fund.
Suven Pharma merges with Cohance Lifesciences to strengthen its CDMO space
Suven Pharmaceuticals (SUVENPHAR) is a pharma company incorporated in 2018, and is engaged in the business of development and manufacturing of new chemical entity-based Intermediates, active pharmaceutical ingredients, specialty chemicals and formulated drugs under contract research and manufacturing services.
In Q3FY24, Suven Pharmaceuticals net profit dropped by 56.6% YoY due to lower revenue and higher inventory costs while revenue declined by 36.2% YoY to Rs 234.2 crore as both the specialty chemicals and pharma segments were impacted. It recently announced a merger with Cohance Lifesciences to strengthen its position in the contract development and manufacturing organisation space. The merger aims to enhance Suven’s overall capacity, and expand its product offerings to customers.
Fund managers who bought shares of Suven Pharmaceuticals
Fund managers who added shares of Suven Pharmaceuticals to their portfolios include Kedar Karnik and Abhishek Singh for DSP Equity & Bond Fund, Amit Premchandani for UTI Value Fund,and Amey Sathe and Aditya Bagul for Tata Flexi Cap Fund. Fresh buys were done by Swapnil Mayekar and Rakesh Shetty for Motilal Oswal Nifty Smallcap 250 ETF, and Mayur Patel for 360 ONE Flexicap Fund.
Aavas Financiers to benefit from upcoming interest rate cuts
Aavas Financiers (AAVAS), formerly known as Au Housing Finance, is engaged in the business of providing housing finance in India. The company has 351 branches in 13 states spread mainly across north and west of India. However, Rajasthan, Maharashtra, Gujarat and Madhya Pradesh comprise 69% of its total geographic distribution.
With borrowing costs at a peak, the company’s margins are currently under pressure. The cost of borrowing increased 73 bps YoY to 7.6% in FY23, but yields increased only marginally by 47 bps YoY to 13.1% due to competitive pricing pressures. However, the company stands to benefit from the rate cut cycle which is expected to start in FY25.
Fund managers who bought shares of Aavas Financiers
Fund managers who added shares of Aavas Financiers to their portfolios include Roshan Chutkey and Sharmila D’mello for ICICI Prudential Banking and Financial Services Fund, Harsh Sethi for SBI Nifty Smallcap 250 Index Fund, and Harsha Upadhyaya and Abhishek Bisen for Kotak Multicap Fund. Fresh buys were done by Anand Laddha and Dhruv Muchhal for HDFC Capital Builder Value Fund, and Karthik Kumar and Mayank Hyanki for Axis Nifty Smallcap 50 Index Fund.
Quess Corp’s demerger to improve valuations
Quess Corp (QUESS), promoted earlier by Fairfax Financial Holdings through its Indian arm, Thomas Cook India, is an integrated business services provider. The company provides technology-enabled staffing and managed outsourcing services across processes such as sales and marketing, customer care, after-sales service, back office operations, etc. It is spread over nine countries and reportedly serves over 3,000 clients.
In Q3FY24, the company reported a revenue increase of 8.4% YoY but net profit declined 27.4% due to higher employee costs. Quess Corp announced a demerger on February 16, into three entities, namely, Quess Corp (workforce management), Digitide Solutions (insurance technology and human resource organization), and Bluspring Enterprises (facility management and industrial services). The demerger aims to improve valuations and enable a focus on pure-play verticals.
Fund managers who bought shares of Quess Corp
Fund managers who added shares of Quess Corp to their portfolios include Manish Gunwani and Rahul Agarwal for Bandhan Core Equity Fund, Hardick Bora and Sanjay Bembalkar for Union Small Cap Fund, Chandraprakash Padiyar and Meeta Shetty for Tata Large & Mid Cap Fund, and Arun Agarwal and Nirman Morakhia HDFC Nifty Smallcap 250 Index Fund. Fresh buys were done by Swapnil Mayekar and Rakesh Shetty for Motilal Oswal Nifty Smallcap 250 ETF.
Mahanagar Gas to benefit from the increasing adoption of CNG
Mahanagar Gas (MGL) is a city gas distribution utilities firm operating in Mumbai, its adjoining areas, and the Raigad district of Maharashtra. The company distributes CNG for use in motor vehicles, and PNG for domestic households and commercial/industrial use. Nearly 70% of the company’s revenue is from CNG sales. The firm has 319 CNG stations under its banner.
In Q3FY24, its net profit grew by 84.3% YoY to Rs 317.2 crore despite a 5.3% YoY fall in its revenue. Margins improved due to a 22.5% decline in input CNG prices. The government plans to raise the share of natural gas in India’s energy mix to 15% by 2030, up from the current 6%. This is expected to boost MGL’s prospects.
Fund managers who bought shares of Mahanagar Gas
Fund managers who added shares of Mahanagar Gas to their portfolios include Dhaval Gala and Dhaval Joshi for Aditya Birla Sun Life PSU Equity Fund, Shreyash Devalkar and Mayank Hyanki for Axis Small Cap Fund,and Amit Premchandani for UTI Value Fund. Fresh buys were done by Sandeep Manam and Rajasa Kakulavarapu for Templeton India Equity Income Fund and Shiv Chanani and Miten Vora for Baroda BNP Paribas Value Fund.